Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

HYKE vs. MSOS: which is better?

Bottom line

HYKE vs MSOS: the short answer

HYKE (Vest 2 Year Interest Rate Hedge ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.

MSOS is cheaper at 0.78% vs 0.93% — a difference of $15 a year per $10,000 invested.

Over one year, MSOS returned +23.4% vs −5.3% for HYKE.

Updated Nov 19, 2026

HYKE vs MSOS side by side

HYKEMSOS
TypeETFETF
Fund familyGrayscaleAdvisorshares
CategoryOtherOther
Expense ratio0.93%0.78%
Annual cost per $10k$93$78
10-yr cost on $10k (prospectus)$1,143$927
Max front loadNoneNone
12b-1 fee0%0%
1-yr return−5.3%+23.4%
5-yr return (annualized)—−33.6%
10-yr return (annualized)——
Best quarter+1.3%+102.2%
Worst quarter−5.9%−50.4%
Net assets (fund)—$1.0B
Number of holdings—61
Portfolio turnover%5%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearHYKEMSOSDifference
2025−5.3%+23.4%−28.6%

Source: Fund prospectus bar charts

Holdings overlap

HYKE and MSOS share none of their top holdings.

HYKE top 10

    MSOS top 10

    1. Curaleaf Holdings Inc — 12.32%
    2. Trulieve Cannabis Corp — 9.56%
    3. Blackrock Treasury Trust — 5.78%
    4. Terrascend Corp — 2.70%
    5. Marex Capital Markets Inc. — 2.16%
    6. Cantor Fitzgerald & Co. — 1.08%
    7. Morgan Stanley & Co. Llc — 0.94%
    8. Glass House Brands Inc — 0.93%
    9. Nomura Securities International, Inc. — 0.85%
    10. Cantor Fitzgerald & Co. — 0.78%

    FAQ

    What is the difference between HYKE and MSOS?
    HYKE (Vest 2 Year Interest Rate Hedge ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs. MSOS is cheaper at 0.78% vs 0.93% — a difference of $15 a year per $10,000 invested.
    Which is cheaper, HYKE or MSOS?
    MSOS has the lower expense ratio (0.78%).
    Should I own both HYKE and MSOS?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.